Contraception News and Research

Latest Contraception News and Research

Viewpoints: GOP should focus on fixing health law; bishops refuse to accept victory

Los Angeles Times: It's Time To Focus On Fixing The Affordable Care Act, Not Gutting It Conservatives have married their political fortunes to the notion that Obamacare is a catastrophe and must be discarded in its entirety -; even though some of the signature elements of the law, such as a requirement that most people be insured, are ideas that they originated.

15 Jul 2013

First Edition: July 12, 2013

Today's early morning highlights from the major news organizations, including articles on data tracking of doctors and comparing the rollout of the Medicare Part D drug plans to implementation of the federal health law.

12 Jul 2013

Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that its phase III study (MM-020/IFM 07-01) of REVLIMID (lenalidomide) in combination with dexamethasone in patients newly diagnosed with multiple myeloma met its primary endpoint of progression-free survival.

11 Jul 2013

Catholic hospital group says it is satisfied with administration's contraceptive compromise

The Catholic Health Association, which has sided with the administration before on the law, said the plan will allow employees to get birth control coverage without the hospitals paying for it.

11 Jul 2013

Viewpoints: Employer mandate: Suspension of the law or bump in the road?

Columnists and editorial boards examine the implications of the postponed employer mandate deadline. In a nutshell, the administration could not figure out how to make sure that businesses with more than 50 full-time employees are providing a minimum level of health insurance.

10 Jul 2013

Employers worry they'll pay bill for those exempt from contraceptive mandate

Businesses are concerned that non-religious employers will end up covering the bill for religious groups that refuse to pay for contraception for their employees. Meanwhile, church leaders continue their push to broaden the exemption from the contraception coverage rule.

4 Jul 2013

Viewpoints: Dems' abortion policies on the wrong side of public opinion; Doctors need to be more accurate in death reports

Last week saw two major developments in the legal and political battle over the Obama administration's sound decision to require most employers to provide free insurance coverage of contraceptives for women under the new health care law -; one of them positive and the other a blow to the mandate and to religious liberty (7/1).

3 Jul 2013

Viewpoints: A 'clever' fix for contraception coverage; Sanjay Gupta warns doctors to pay attention to health overhaul

Many nonprofit religious organizations have balked at having to insure their employees' birth control -- because they don't believe in artificial contraception -- under the Affordable Care Act. On Friday, the Obama administration announced a solution to this problem. The new health care law guarantees access to preventive services, and contraception falls, appropriately, into that category (Carla Hill, 6/28).

2 Jul 2013

Contraceptive exemption for religious groups finalized

The rule, issued under the health care law, attempts to quell the controversy by balancing the interests of women with the concerns of the Roman Catholic Church and other employers with religious objections to providing coverage for contraceptives.

2 Jul 2013

First Edition: July 1, 2013

Today's headlines include a variety of weekend news reports, including coverage of the Obama administration's final contraceptive coverage rule as well as a range of other stories on health law implementation issues.

1 Jul 2013

Appeals court green lights Hobby Lobby's legal challenge to contraceptive coverage rule

A federal appeals court in Denver said Thursday that companies, whether they are for profit or not, have religious rights and that the challenge brought by Hobby Lobby Stores Inc. and its sister company can go forward.

29 Jun 2013

EMA's CHMP issues positive opinion for approval of Genzyme's LEMTRADA in Europe

Genzyme, a Sanofi company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion for approval of LEMTRADA (alemtuzumab) for the treatment of adult patients with relapsing remitting multiple sclerosis with active disease defined by clinical or imaging features.

28 Jun 2013

First Edition: June 28, 2013

Today's headlines include reports that the high court sent a tentative signal Thursday that it was moving toward hearing a case on the regulation of abortion-inducing drugs.

28 Jun 2013

Florida firm gets religious reprieve from health law's contraception coverage rule; W.Va. auto dealer seeks relief

An update on employers' legal challenges to the provisions requiring contraceptive coverage.

28 Jun 2013

European regulators grant CE Mark approval for single-size SILCS Diaphragm

Soon, women in Europe may be taking a new look at one of the world's oldest forms of contraception. European regulators have granted the single-size SILCS Diaphragm a CE marking, allowing the product to be sold throughout Europe. The launch is also an important step toward expanding nonhormonal contraception options for women worldwide.

21 Jun 2013

European Commission amends marketing authorisation for Celgene's REVLIMID

Celgene International Sàrl was today notified that the European Commission has amended the marketing authorisation for REVLIMID. This decision means that REVLIMID is now approved to treat patients with transfusion-dependent anaemia due to low or intermediate-1 risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate.

17 Jun 2013